The new modified ABCD method for gastric neoplasm screening
详细信息    查看全文
  • 作者:Chan Hyuk Park ; Eun Hye Kim ; Da Hyun Jung ; Hyunsoo Chung ; Jun Chul Park
  • 关键词:ABCD method ; IgG anti ; Helicobacter pylori antibody ; Pepsinogen ; Gastric cancer ; Gastric adenoma
  • 刊名:Gastric Cancer
  • 出版年:2016
  • 出版时间:January 2016
  • 年:2016
  • 卷:19
  • 期:1
  • 页码:128-135
  • 全文大小:868 KB
  • 参考文献:1.Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.PubMed CrossRef
    2.Yokota T, Kunii Y, Teshima S, Yamada Y, Saito T, Takahashi M, et al. Significant prognostic factors in patients with early gastric cancer. Int Surg. 2000;85:286–90.PubMed
    3.Siewert JR, Böttcher K, Stein HJ, Roder JD. Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg. 1998;228:449–61.PubMed PubMedCentral CrossRef
    4.Lee HJ, Yang HK, Ahn YO. Gastric cancer in Korea. Gastric Cancer. 2002;5:177–82.PubMed CrossRef
    5.Nishi M, Ishihara S, Nakajima T, Ohta K, Ohyama S, Ohta H. Chronological changes of characteristics of early gastric cancer and therapy: experience in the Cancer Institute Hospital of Tokyo, 1950-1994. J Cancer Res Clin Oncol. 1995;121:535–41.PubMed CrossRef
    6.National cancer control programs in Korea. J Korean Med Sci. 2007;22(Suppl):S3–4.CrossRef
    7.Park CH, Kim EH, Chung H, Lee H, Park JC, Shin SK, et al. The optimal endoscopic screening interval for detecting early gastric neoplasms. Gastrointest Endosc. 2014;80:253–9.PubMed CrossRef
    8.Ohata H, Kitauchi S, Yoshimura N, Mugitani K, Iwane M, Nakamura H, et al. Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer. Int J Cancer. 2004;109:138–43.PubMed CrossRef
    9.Miki K. Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels—”ABC method”. Proc Jpn Acad Ser B Phys Biol Sci. 2011;87:405–14.PubMed PubMedCentral CrossRef
    10.Miki K, Ichinose M, Shimizu A, Huang SC, Oka H, Furihata C, et al. Serum pepsinogens as a screening test of extensive chronic gastritis. Gastroenterol Jpn. 1987;22:133–41.PubMed
    11.Watabe H, Mitsushima T, Yamaji Y, Okamoto M, Wada R, Kokubo T, et al. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut. 2005;54:764–8.PubMed PubMedCentral CrossRef
    12.Mizuno S, Miki I, Ishida T, Yoshida M, Onoyama M, Azuma T, et al. Prescreening of a high-risk group for gastric cancer by serologically determined Helicobacter pylori infection and atrophic gastritis. Dig Dis Sci. 2010;55:3132–7.PubMed CrossRef
    13.Yamaji Y, Mitsushima T, Ikuma H, Okamoto M, Yoshida H, Kawabe T, et al. Inverse background of Helicobacter pylori antibody and pepsinogen in reflux oesophagitis compared with gastric cancer: analysis of 5732 Japanese subjects. Gut. 2001;49:335–40.PubMed PubMedCentral CrossRef
    14.Kudo T, Kakizaki S, Sohara N, Onozato Y, Okamura S, Inui Y, et al. Analysis of ABC (D) stratification for screening patients with gastric cancer. World J Gastroenterol. 2011;17:4793–8.PubMed PubMedCentral CrossRef
    15.Lorente S, Doiz O, Trinidad Serrano M, Castillo J, Lanas A. Helicobacter pylori stimulates pepsinogen secretion from isolated human peptic cells. Gut. 2002;50:13–8.PubMed PubMedCentral CrossRef
    16.Kim HY, Kim N, Kang JM, Park YS, Lee DH, Kim YR, et al. Clinical meaning of pepsinogen test and Helicobacter pylori serology in the health check-up population in Korea. Eur J Gastroenterol Hepatol. 2009;21:606–12.PubMed CrossRef
    17.Bölükbaş C, Bölükbaş F, Ovünç O, Kiliç G, Dalay R, Güven H, et al. Relationship between Helicobacter pylori status and serum pepsinogens as serologic markers in atrophic gastritis. Turk J Gastroenterol. 2006;17:172–6.PubMed
    18.Correa P. A human model of gastric carcinogenesis. Cancer Res. 1988;48:3554–60.PubMed
    19.Vieth M, Stolte M. Elevated risk for gastric adenocarcinoma can be predicted from histomorphology. World J Gastroenterol. 2006;12:6109–14.PubMed PubMedCentral
    20.Adamu MA, Weck MN, Gao L, Brenner H. Incidence of chronic atrophic gastritis: systematic review and meta-analysis of follow-up studies. Eur J Epidemiol. 2010;25:439–48.PubMed CrossRef
  • 作者单位:Chan Hyuk Park (1)
    Eun Hye Kim (1)
    Da Hyun Jung (1)
    Hyunsoo Chung (1)
    Jun Chul Park (1)
    Sung Kwan Shin (1)
    Sang Kil Lee (1)
    Yong Chan Lee (1)

    1. Division of Gastroenterology, Department of Internal Medicine, Severance Hospital, Institute of Gastroenterology, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 120-752, Republic of Korea
  • 刊物类别:Medicine
  • 刊物主题:Medicine & Public Health
    Oncology
    Gastroenterology
    Surgical Oncology
    Pathology
    Radiotherapy
  • 出版者:Springer Japan
  • ISSN:1436-3305
文摘
Background The ABCD screening method was developed for risk stratification of gastric cancer. It is unclear whether the ABCD method can predict the risk of gastric neoplasms, including gastric adenomas, as observed for gastric cancer. We aimed to devise a modified ABCD method for predicting gastric neoplasms.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700